231 related articles for article (PubMed ID: 11669362)
1. Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting.
Waddell D; Rein A; Panarites C; Coleman PM; Weiss C
Am J Manag Care; 2001 Oct; 7(10):981-91. PubMed ID: 11669362
[TBL] [Abstract][Full Text] [Related]
2. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
[TBL] [Abstract][Full Text] [Related]
3. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
Waddell DD; Cefalu CA; Bricker DC
Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
[TBL] [Abstract][Full Text] [Related]
4. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
Kemper F; Gebhardt U; Meng T; Murray C
Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
[TBL] [Abstract][Full Text] [Related]
6. The use of hylan G-F 20 after knee arthroscopy in an active patient population with knee osteoarthritis.
Zietz PM; Selesnick H
Arthroscopy; 2008 Apr; 24(4):416-22. PubMed ID: 18375273
[TBL] [Abstract][Full Text] [Related]
7. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
Wobig M; Bach G; Beks P; Dickhut A; Runzheimer J; Schwieger G; Vetter G; Balazs E
Clin Ther; 1999 Sep; 21(9):1549-62. PubMed ID: 10509850
[TBL] [Abstract][Full Text] [Related]
8. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review.
Waddell DD; Bricker DC
J Surg Orthop Adv; 2006; 15(1):53-9. PubMed ID: 16603113
[TBL] [Abstract][Full Text] [Related]
9. Predictors of clinical response to intraarticular Hylan injections -- a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging.
Anandacoomarasamy A; Bagga H; Ding C; Burkhardt D; Sambrook PN; March LM
J Rheumatol; 2008 Apr; 35(4):685-90. PubMed ID: 18278831
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
Jüni P; Reichenbach S; Trelle S; Tschannen B; Wandel S; Jordi B; Züllig M; Guetg R; Häuselmann HJ; Schwarz H; Theiler R; Ziswiler HR; Dieppe PA; Villiger PM; Egger M;
Arthritis Rheum; 2007 Nov; 56(11):3610-9. PubMed ID: 17968921
[TBL] [Abstract][Full Text] [Related]
11. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.
Bagga H; Burkhardt D; Sambrook P; March L
J Rheumatol; 2006 May; 33(5):946-50. PubMed ID: 16652425
[TBL] [Abstract][Full Text] [Related]
12. Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections?
Pullman-Mooar S; Mooar P; Sieck M; Clayburne G; Schumacher HR
J Rheumatol; 2002 Dec; 29(12):2611-4. PubMed ID: 12465161
[TBL] [Abstract][Full Text] [Related]
13. Functional outcome in knee osteoarthritis after treatment with hylan G-F 20: a prospective study.
Goorman SD; Watanabe TK; Miller EH; Perry C
Arch Phys Med Rehabil; 2000 Apr; 81(4):479-83. PubMed ID: 10768539
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized trial comparing the efficacy of single 6-ml injection of hylan G-F 20 and hyaluronic acid for primary knee arthritis: a preliminary study.
Khanasuk Y; Dechmaneenin T; Tanavalee A
J Med Assoc Thai; 2012 Oct; 95 Suppl 10():S92-7. PubMed ID: 23451445
[TBL] [Abstract][Full Text] [Related]
15. Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK).
Clarke S; Lock V; Duddy J; Sharif M; Newman JH; Kirwan JR
Knee; 2005 Jan; 12(1):57-62. PubMed ID: 15664879
[TBL] [Abstract][Full Text] [Related]
16. Use of Hylan G-F 20 for viscosupplementation of the temporomandibular joint for the management of osteoarthritis: a case report.
Yustin D; Kryshtalskyj B; Galea A
J Orofac Pain; 1995; 9(4):375-9. PubMed ID: 8995909
[TBL] [Abstract][Full Text] [Related]
17. Cost analysis of intra-articular sodium hyaluronate treatment in knee osteoarthritis patients who failed conservative treatment.
Turajane T; Labpiboonpong V; Maungsiri S
J Med Assoc Thai; 2007 Sep; 90(9):1839-44. PubMed ID: 17957928
[TBL] [Abstract][Full Text] [Related]
18. BLISS index for analyzing knee osteoarthritis trials data.
Bellamy N; Bell MJ; Pericak D; Goldsmith CH; Torrance GW; Raynauld JP; Walker V; Tugwell P; Polisson R
J Clin Epidemiol; 2007 Feb; 60(2):124-32. PubMed ID: 17208118
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of hylan G-F 20 for symptomatic glenohumeral osteoarthritis: a prospective, pilot study.
Brander VA; Gomberawalla A; Chambers M; Bowen M; Nuber G
PM R; 2010 Apr; 2(4):259-67. PubMed ID: 20430327
[TBL] [Abstract][Full Text] [Related]
20. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada.
Lussier A; Cividino AA; McFarlane CA; Olszynski WP; Potashner WJ; De Médicis R
J Rheumatol; 1996 Sep; 23(9):1579-85. PubMed ID: 8877928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
